載入中
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
收盤時
US$3.77
−US$0.12 · -3.08%
盤後
US$3.84
+US$0.07 · +1.86%
10月12日 下午6:00 ET
盤中時間採用ET。市場資料可能有所延遲。
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
日內區間
目前US$3.77
52週區間
目前US$3.77
盤中時間採用ET。市場資料可能有所延遲。
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
日內區間
目前US$3.77
52週區間
目前US$3.77
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
